Zkusit zdarma
Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

AGIO
Cena:
$ 28.14
-0.65 (-2.26%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Avanzanite Bioscience's Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia

Avanzanite Bioscience's Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia

10:18 22-05-2026

AMSTERDAM--(BUSINESS WIRE)-- #Avanzanite--Avanzanite Bioscience B.V., a rapidly growing commercial-s...

Agios' PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia

Agios' PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia

9:15 22-05-2026

PYRUKYND is the only medicine approved in the EU for adults with transfusion-dependent and non-trans...

Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances

Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances

13:04 19-05-2026

Agios Pharmaceuticals NASDAQ: AGIO executives said the company is focused on advancing mitapivat acr...

Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease

Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease

12:25 13-05-2026

AGIO seeks FDA accelerated approval for mitapivat in sickle cell disease after mixed phase III data ...

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

9:31 12-05-2026

sNDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated a...

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

9:30 12-05-2026

Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for disting...

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)

7:55 02-05-2026

The company faces competitive pressure from Novo Nordisk, but it's growing sales from its existing a...

AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum

AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum

15:35 30-04-2026

Agios shares jump 13% as Q1 revenues surge 138% on Aqvesme launch and Pyrukynd growth, while pipelin...

Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday

Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday

18:27 29-04-2026

There's power in the company's No. 1 molecule....

Agios Pharmaceuticals, Inc. (AGIO) Q1 2026 Earnings Call Transcript

Agios Pharmaceuticals, Inc. (AGIO) Q1 2026 Earnings Call Transcript

15:01 29-04-2026

Agios Pharmaceuticals, Inc. (AGIO) Q1 2026 Earnings Call Transcript...

Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates

8:46 29-04-2026

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.69 per share versus the Zacks Cons...

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

6:30 29-04-2026

Mitapivat (PYRUKYND® and AQVESME™) generated worldwide net revenues of $20.7 million in the first...

Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026)

Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026)

5:36 24-04-2026

A rival company's trial results had a negative impact on Agios' stock this week....

Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline

Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline

11:01 22-04-2026

Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a ...

Here's Why Agios Pharmaceuticals Crashed 23% Today

Here's Why Agios Pharmaceuticals Crashed 23% Today

12:19 20-04-2026

The market is concerned about the diminished market potential for Agios' mitapavit following today's...

SG Americas Securities LLC Increases Position in Agios Pharmaceuticals, Inc. $AGIO

SG Americas Securities LLC Increases Position in Agios Pharmaceuticals, Inc. $AGIO

5:18 08-04-2026

SG Americas Securities LLC raised its position in Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) by 68.0...

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

7:00 06-04-2026

CAMBRIDGE, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a c...

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

12:16 01-04-2026

Agios Pharmaceuticals jumps 14% as it moves toward accelerated FDA approval for mitapivat in sickle ...

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

9:00 01-04-2026

NEW YORK, April 1, 2026 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an...

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

6:50 01-04-2026

Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading v...

close

AGIOS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

12-02-2026
PYRUKYND® (MITAPIVAT) WORLDWIDE NET REVENUES OF $20.0 MILLION IN FOURTH QUARTER AND $54.0 MILLION F...
Více zde

AGIOS TO HOST FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON FEBRUARY 12 AT 8:00 A.M. ET

26-01-2026
CAMBRIDGE, MASS., JAN. 26, 2026 (GLOBE NEWSWIRE) -- AGIOS PHARMACEUTICALS, INC. (NASDAQ: AGIO), A CO...
Více zde

AGIOS OUTLINES 2026 STRATEGIC PRIORITIES AND KEY MILESTONES TO ACCELERATE RARE DISEASE PORTFOLIO GROWTH

12-01-2026
AQVESME™ (MITAPIVAT) U.S. COMMERCIAL LAUNCH IN THALASSEMIA UNDERWAY FOLLOWING DECEMBER 2025 FDA AP...
Více zde

AGIOS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE ON JANUARY 14, 2026

05-01-2026
AGIOS TODAY ANNOUNCED THAT ITS MANAGEMENT TEAM IS SCHEDULED TO PRESENT AT THE 44TH ANNUAL J.P. MORGA...
Více zde

U.S. FDA APPROVES AGIOS' AQVESME™ (MITAPIVAT) FOR THE TREATMENT OF ANEMIA IN ADULTS WITH ALPHA- OR BETA-THALASSEMIA

23-12-2025
AQVESME IS THE ONLY FDA-APPROVED MEDICINE FOR ANEMIA IN BOTH NON-TRANSFUSION-DEPENDENT AND TRANSFUSI...
Více zde

AGIOS PROVIDES UPDATE ON U.S. SNDA FOR MITAPIVAT IN THALASSEMIA

08-12-2025
AGIOS TODAY ANNOUNCED THAT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS NOT YET ISSUED A REGULATO...
Více zde

AGIOS ANNOUNCES TOPLINE RESULTS FROM RISE UP PHASE 3 TRIAL OF MITAPIVAT IN SICKLE CELL DISEASE

19-11-2025
TRIAL MET PRIMARY ENDPOINT OF HEMOGLOBIN RESPONSE AND KEY SECONDARY ENDPOINTS OF CHANGE FROM BASELIN...
Více zde

AGIOS TO PRESENT NEW MITAPIVAT DATA IN RARE BLOOD DISORDERS AT 67TH ASH ANNUAL MEETING AND EXPOSITION

03-11-2025
CAMBRIDGE, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- AGIOS PHARMACEUTICALS, INC. (NASDAQ: AGIO), A CO...
Více zde

AGIOS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

30-10-2025
$12.9 MILLION IN THIRD QUARTER PYRUKYND® (MITAPIVAT) NET REVENUES PDUFA GOAL DATE FOR PYRUKYND U.S....
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

18-10-2025
NEW YORK , OCT. 18, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

AVANZANITE BIOSCIENCE'S PARTNER AGIOS ANNOUNCES POSITIVE CHMP OPINION FOR PYRUKYND® (MITAPIVAT) FOR ADULTS WITH THALASSEMIA

17-10-2025
AMSTERDAM--(BUSINESS WIRE)-- #BIOPHARMA--AVANZANITE'S PARTNER AGIOS PHARMACEUTICALS ANNOUNCES REGULA...
Více zde

AGIOS' PYRUKYND® (MITAPIVAT) RECEIVES POSITIVE CHMP OPINION FOR ADULTS WITH THALASSEMIA

17-10-2025
AGIOS TODAY ANNOUNCED THAT THE CHMP HAS ADOPTED A POSITIVE OPINION FOR THE NEW INDICATION FOR PYRUKY...
Více zde

AGIOS TO HOST THIRD QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON OCTOBER 30 AT 8:00 A.M. ET

16-10-2025
CAMBRIDGE, MASS. , OCT. 16, 2025 (GLOBE NEWSWIRE) -- AGIOS PHARMACEUTICALS, INC. (NASDAQ: AGIO), A C...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

13-10-2025
NEW YORK , OCT. 13, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

08-10-2025
NEW YORK , OCT. 8, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

03-10-2025
NEW YORK , OCT. 3, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

28-09-2025
NEW YORK , SEPT. 28, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVEST...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. – AGIO

24-09-2025
NEW YORK, SEPT. 24, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

23-09-2025
NEW YORK , SEPT. 23, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

18-09-2025
NEW YORK , SEPT. 18, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

AGIO INVESTORS HAVE OPPORTUNITY TO JOIN AGIOS PHARMACEUTICALS, INC. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

18-09-2025
LOS ANGELES , SEPT. 18, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITI...
Více zde

AGIO INVESTORS HAVE OPPORTUNITY TO JOIN AGIOS PHARMACEUTICALS, INC. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

15-09-2025
LOS ANGELES--(BUSINESS WIRE)---- $AGIO--AGIO INVESTORS HAVE OPPORTUNITY TO JOIN AGIOS PHARMACEUTICAL...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

13-09-2025
NEW YORK , SEPT. 13, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. – AGIO

10-09-2025
NEW YORK, SEPT. 10, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AGIOS PHARMACEUTICALS, INC. - AGIO

08-09-2025
NEW YORK , SEPT. 8, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

AGIOS PROVIDES UPDATE ON U.S. PDUFA GOAL DATE FOR PYRUKYND® (MITAPIVAT) IN THALASSEMIA

04-09-2025
PDUFA GOAL DATE EXTENDED BY THREE MONTHS FROM SEPTEMBER 7, 2025, TO DECEMBER 7, 2025 CAMBRIDGE, MASS...
Více zde

AGIOS' PYRUKYND® (MITAPIVAT) APPROVED FOR ADULTS WITH THALASSEMIA IN SAUDI ARABIA

04-08-2025
AGIOS PHARMACEUTICALS TODAY ANNOUNCED THAT THE SAUDI FOOD AND DRUG AUTHORITY HAS APPROVED PYRUKYND®...
Více zde

AGIOS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

31-07-2025
$12.5 MILLION IN SECOND QUARTER PYRUKYND® (MITAPIVAT) NET REVENUES; ENDED SECOND QUARTER WITH $1.3 ...
Více zde

AGIOS TO HOST WEBCAST CONFERENCE CALL OF SECOND QUARTER FINANCIAL RESULTS ON JULY 31, 2025 AT 8:00AM ET

14-07-2025
CAMBRIDGE, MASS., JULY 14, 2025 (GLOBE NEWSWIRE) -- AGIOS PHARMACEUTICALS, INC. (NASDAQ: AGIO), A LE...
Více zde

AGIOS APPOINTS DR. JAY BACKSTROM TO BOARD OF DIRECTORS

08-07-2025
CAMBRIDGE, MASS., JULY 08, 2025 (GLOBE NEWSWIRE) -- AGIOS PHARMACEUTICALS, INC. (NASDAQ: AGIO), A LE...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-12 00:00:008-KStáhnout
2026-02-12 00:00:0010-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-10-30 00:00:008-KStáhnout
2025-10-30 00:00:0010-QStáhnout
2025-08-04 01:00:008-KStáhnout
2025-08-04 00:00:008-KStáhnout
2025-07-31 01:00:008-KStáhnout
2025-07-31 01:00:0010-QStáhnout
2025-07-31 00:00:008-KStáhnout
2025-07-31 00:00:0010-QStáhnout
2025-07-08 01:00:008-KStáhnout
2025-07-08 00:00:008-KStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 01:00:0010-QStáhnout
2025-05-01 00:00:008-KStáhnout
2025-05-01 00:00:0010-QStáhnout
2025-02-13 00:00:008-KStáhnout
2025-02-13 00:00:0010-KStáhnout
2025-02-12 23:00:008-KStáhnout
2025-02-12 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2025-01-06 00:00:008-KStáhnout
2025-01-05 23:00:008-KStáhnout
2024-10-31 00:00:008-KStáhnout
2024-10-31 00:00:0010-QStáhnout
2024-10-30 23:00:008-KStáhnout
2024-10-30 23:00:0010-QStáhnout
2024-08-01 01:00:008-KStáhnout
2024-08-01 01:00:0010-QStáhnout
2024-08-01 00:00:008-KStáhnout
2024-08-01 00:00:0010-QStáhnout
2024-06-20 01:00:008-KStáhnout
2024-06-20 00:00:008-KStáhnout
2024-05-28 01:00:008-KStáhnout
2024-05-28 00:00:008-KStáhnout
2024-05-02 01:00:008-KStáhnout
2024-05-02 01:00:0010-QStáhnout
2024-05-02 00:00:008-KStáhnout
2024-05-02 00:00:0010-QStáhnout
2024-02-15 00:00:008-KStáhnout
2024-02-15 00:00:0010-KStáhnout
2024-02-14 23:00:008-KStáhnout
2024-02-14 23:00:0010-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-06-14 01:00:008-KStáhnout
2023-06-14 00:00:008-KStáhnout
2023-05-25 01:00:008-KStáhnout
2023-05-25 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-19 01:00:008-KStáhnout
2023-04-19 00:00:008-KStáhnout
2023-03-03 00:00:008-KStáhnout
2023-03-02 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-16 00:00:008-KStáhnout
2022-12-15 23:00:008-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-10-27 01:00:008-KStáhnout
2022-10-27 00:00:008-KStáhnout
2022-10-07 01:00:008-KStáhnout
2022-10-07 00:00:008-KStáhnout
2022-09-19 01:00:008-KStáhnout
2022-09-19 00:00:008-KStáhnout
2022-09-07 01:00:008-KStáhnout
2022-09-07 00:00:008-KStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-07-12 01:00:008-KStáhnout
2022-07-12 00:00:008-KStáhnout
2022-06-22 01:00:008-KStáhnout
2022-06-22 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-18 01:00:008-KStáhnout
2022-05-18 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-04-26 01:00:008-KStáhnout
2022-04-26 00:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-01-14 00:00:008-KStáhnout
2022-01-13 23:00:008-KStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-03 00:00:0010-QStáhnout
2021-11-02 23:00:008-KStáhnout
2021-11-02 23:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 00:00:008-KStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 01:00:0010-QStáhnout
2021-07-29 00:00:008-KStáhnout
2021-07-29 00:00:0010-QStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-06-11 01:00:008-KStáhnout
2021-06-11 00:00:008-KStáhnout
2021-05-21 01:00:008-KStáhnout
2021-05-21 00:00:008-KStáhnout
2021-04-29 01:00:008-KStáhnout
2021-04-29 01:00:0010-QStáhnout
2021-04-29 00:00:008-KStáhnout
2021-04-29 00:00:0010-QStáhnout
2021-04-06 01:00:008-KStáhnout
2021-04-06 00:00:008-KStáhnout
2021-04-02 01:00:008-KStáhnout
2021-04-02 00:00:008-KStáhnout
2021-03-25 00:00:008-KStáhnout
2021-03-24 23:00:008-KStáhnout
2021-03-15 00:00:008-KStáhnout
2021-03-14 23:00:008-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-01-29 00:00:008-KStáhnout
2021-01-28 23:00:008-KStáhnout
2021-01-26 00:00:008-KStáhnout
2021-01-25 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-22 00:00:008-KStáhnout
2020-12-21 23:00:008-KStáhnout
2020-12-21 00:00:008-KStáhnout
2020-12-20 23:00:008-KStáhnout
2020-12-07 00:00:008-KStáhnout
2020-12-06 23:00:008-KStáhnout
2020-12-01 00:00:008-KStáhnout
2020-11-30 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-09-21 01:00:008-KStáhnout
2020-09-21 00:00:008-KStáhnout
2020-09-08 01:00:008-KStáhnout
2020-09-08 00:00:008-KStáhnout
2020-07-30 01:00:008-KStáhnout
2020-07-30 01:00:0010-QStáhnout
2020-07-30 00:00:008-KStáhnout
2020-07-30 00:00:0010-QStáhnout
2020-06-12 01:00:008-KStáhnout
2020-06-12 00:00:008-KStáhnout
2020-05-29 01:00:008-KStáhnout
2020-05-29 00:00:008-KStáhnout
2020-04-30 01:00:008-KStáhnout
2020-04-30 01:00:0010-QStáhnout
2020-04-30 00:00:008-KStáhnout
2020-04-30 00:00:0010-QStáhnout
2020-02-19 00:00:0010-KStáhnout
2020-02-18 23:00:0010-KStáhnout
2020-02-13 00:00:008-KStáhnout
2020-02-12 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-12-09 00:00:008-KStáhnout
2019-12-08 23:00:008-KStáhnout
2019-11-22 00:00:008-KStáhnout
2019-11-21 23:00:008-KStáhnout
2019-11-08 00:00:008-KStáhnout
2019-11-07 23:00:008-KStáhnout
2019-11-04 00:00:008-KStáhnout
2019-11-03 23:00:008-KStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-31 00:00:0010-QStáhnout
2019-10-30 23:00:008-KStáhnout
2019-10-30 23:00:0010-QStáhnout
2019-10-28 00:00:008-KStáhnout
2019-10-27 23:00:008-KStáhnout
2019-09-30 01:00:008-KStáhnout
2019-09-30 00:00:008-KStáhnout
2019-09-04 01:00:008-KStáhnout
2019-09-04 00:00:008-KStáhnout
2019-08-01 01:00:008-KStáhnout
2019-08-01 01:00:0010-QStáhnout
2019-08-01 00:00:008-KStáhnout
2019-08-01 00:00:0010-QStáhnout
2019-06-05 01:00:008-KStáhnout
2019-06-05 00:00:008-KStáhnout
2019-06-03 01:00:008-KStáhnout
2019-06-03 00:00:008-KStáhnout
2019-05-31 01:00:008-KStáhnout
2019-05-31 00:00:008-KStáhnout
2019-05-15 01:00:008-KStáhnout
2019-05-15 00:00:008-KStáhnout
2019-05-02 01:00:008-KStáhnout
2019-05-02 01:00:0010-QStáhnout
2019-05-02 00:00:008-KStáhnout
2019-05-02 00:00:0010-QStáhnout
2019-04-16 01:00:008-KStáhnout
2019-04-16 00:00:008-KStáhnout
2019-02-26 00:00:008-KStáhnout
2019-02-25 23:00:008-KStáhnout
2019-02-14 00:00:008-KStáhnout
2019-02-14 00:00:0010-KStáhnout
2019-02-13 23:00:008-KStáhnout
2019-02-13 23:00:0010-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-12-19 00:00:008-KStáhnout
2018-12-18 23:00:008-KStáhnout
2018-12-03 00:00:008-KStáhnout
2018-12-02 23:00:008-KStáhnout
2018-11-16 00:00:008-KStáhnout
2018-11-15 23:00:008-KStáhnout
2018-11-01 00:00:008-KStáhnout
2018-11-01 00:00:0010-QStáhnout
2018-10-31 23:00:008-KStáhnout
2018-10-31 23:00:0010-QStáhnout
2018-09-05 01:00:008-KStáhnout
2018-09-05 00:00:008-KStáhnout
2018-08-02 01:00:008-KStáhnout
2018-08-02 01:00:0010-QStáhnout
2018-08-02 00:00:008-KStáhnout
2018-08-02 00:00:0010-QStáhnout
2018-07-20 01:00:008-KStáhnout
2018-07-20 00:00:008-KStáhnout
2018-06-29 01:00:008-KStáhnout
2018-06-29 00:00:008-KStáhnout
2018-06-04 01:00:008-KStáhnout
2018-06-04 00:00:008-KStáhnout
2018-06-01 01:00:008-KStáhnout
2018-06-01 00:00:008-KStáhnout
2018-05-04 01:00:008-KStáhnout
2018-05-04 01:00:0010-QStáhnout
2018-05-04 00:00:008-KStáhnout
2018-05-04 00:00:0010-QStáhnout
2018-04-13 01:00:008-KStáhnout
2018-04-13 00:00:008-KStáhnout
2018-02-14 00:00:008-KStáhnout
2018-02-14 00:00:0010-KStáhnout
2018-02-13 23:00:008-KStáhnout
2018-02-13 23:00:0010-KStáhnout
2018-01-19 00:00:008-KStáhnout
2018-01-18 23:00:008-KStáhnout
2018-01-08 00:00:008-KStáhnout
2018-01-07 23:00:008-KStáhnout
2017-12-19 00:00:008-KStáhnout
2017-12-18 23:00:008-KStáhnout
2017-12-11 00:00:008-KStáhnout
2017-12-10 23:00:008-KStáhnout
2017-12-05 00:00:008-KStáhnout
2017-12-04 23:00:008-KStáhnout
2017-11-22 00:00:008-KStáhnout
2017-11-21 23:00:008-KStáhnout
2017-11-17 00:00:008-KStáhnout
2017-11-16 23:00:008-KStáhnout
2017-11-01 00:00:008-KStáhnout
2017-11-01 00:00:0010-QStáhnout
2017-10-31 23:00:008-KStáhnout
2017-10-31 23:00:0010-QStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-08-01 01:00:008-KStáhnout
2017-08-01 00:00:008-KStáhnout
2017-06-26 01:00:008-KStáhnout
2017-06-26 00:00:008-KStáhnout
2017-06-14 01:00:008-KStáhnout
2017-06-14 00:00:008-KStáhnout
2017-06-06 01:00:008-KStáhnout
2017-06-06 00:00:008-KStáhnout
2017-05-31 01:00:008-KStáhnout
2017-05-31 00:00:008-KStáhnout
2017-05-05 01:00:008-KStáhnout
2017-05-05 00:00:008-KStáhnout
2017-05-04 01:00:008-KStáhnout
2017-05-04 01:00:0010-QStáhnout
2017-05-04 00:00:008-KStáhnout
2017-05-04 00:00:0010-QStáhnout
2017-04-19 01:00:008-KStáhnout
2017-04-19 00:00:008-KStáhnout
2017-03-13 00:00:008-KStáhnout
2017-03-12 23:00:008-KStáhnout
2017-02-16 00:00:008-KStáhnout
2017-02-16 00:00:0010-KStáhnout
2017-02-15 23:00:008-KStáhnout
2017-02-15 23:00:0010-KStáhnout
2017-01-09 00:00:008-KStáhnout
2017-01-08 23:00:008-KStáhnout
2017-01-04 00:00:008-KStáhnout
2017-01-03 23:00:008-KStáhnout
2016-12-15 00:00:008-KStáhnout
2016-12-14 23:00:008-KStáhnout
2016-12-06 00:00:008-KStáhnout
2016-12-05 23:00:008-KStáhnout
2016-11-18 00:00:008-KStáhnout
2016-11-17 23:00:008-KStáhnout
2016-11-09 00:00:008-KStáhnout
2016-11-08 23:00:008-KStáhnout
2016-11-03 00:00:008-KStáhnout
2016-11-03 00:00:0010-QStáhnout
2016-11-02 23:00:008-KStáhnout
2016-11-02 23:00:0010-QStáhnout
2016-09-15 01:00:008-KStáhnout
2016-09-15 00:00:008-KStáhnout
2016-09-07 01:00:008-KStáhnout
2016-09-07 00:00:008-KStáhnout
2016-08-26 01:00:008-KStáhnout
2016-08-26 00:00:008-KStáhnout
2016-08-16 01:00:008-KStáhnout
2016-08-16 00:00:008-KStáhnout
2016-08-08 01:00:0010-QStáhnout
2016-08-08 00:00:0010-QStáhnout
2016-08-04 01:00:008-KStáhnout
2016-08-04 00:00:008-KStáhnout
2016-06-22 01:00:008-KStáhnout
2016-06-22 00:00:008-KStáhnout
2016-06-13 01:00:008-KStáhnout
2016-06-13 00:00:008-KStáhnout
2016-05-23 01:00:008-KStáhnout
2016-05-23 00:00:008-KStáhnout
2016-05-09 01:00:0010-QStáhnout
2016-05-09 00:00:0010-QStáhnout
2016-05-05 01:00:008-KStáhnout
2016-05-05 00:00:008-KStáhnout
2016-04-22 01:00:008-KStáhnout
2016-04-22 00:00:008-KStáhnout
2016-04-14 01:00:008-KStáhnout
2016-04-14 00:00:008-KStáhnout
2016-02-26 00:00:0010-KStáhnout
2016-02-25 23:00:0010-KStáhnout
2016-02-18 00:00:008-KStáhnout
2016-02-17 23:00:008-KStáhnout
2016-02-08 00:00:008-KStáhnout
2016-02-07 23:00:008-KStáhnout
2016-02-05 00:00:008-KStáhnout
2016-02-04 23:00:008-KStáhnout
2016-01-11 00:00:008-KStáhnout
2016-01-10 23:00:008-KStáhnout
2015-12-07 00:00:008-KStáhnout
2015-12-06 23:00:008-KStáhnout
2015-12-04 00:00:008-KStáhnout
2015-12-03 23:00:008-KStáhnout
2015-11-09 00:00:008-KStáhnout
2015-11-08 23:00:008-KStáhnout
2015-11-06 00:00:0010-QStáhnout
2015-11-05 23:00:0010-QStáhnout
2015-11-05 00:00:008-KStáhnout
2015-11-04 23:00:008-KStáhnout
2015-10-16 01:00:008-KStáhnout
2015-10-16 00:00:008-KStáhnout
2015-08-07 01:00:0010-QStáhnout
2015-08-07 00:00:0010-QStáhnout
2015-08-06 01:00:008-KStáhnout
2015-08-06 00:00:008-KStáhnout
2015-07-23 01:00:008-KStáhnout
2015-07-23 00:00:008-KStáhnout
2015-06-24 01:00:008-KStáhnout
2015-06-24 00:00:008-KStáhnout
2015-05-11 01:00:0010-QStáhnout
2015-05-11 00:00:0010-QStáhnout
2015-05-07 01:00:008-KStáhnout
2015-05-07 00:00:008-KStáhnout
2015-05-01 01:00:008-KStáhnout
2015-05-01 00:00:008-KStáhnout
2015-03-13 00:00:008-KStáhnout
2015-03-12 23:00:008-KStáhnout
2015-02-24 00:00:0010-KStáhnout
2015-02-23 23:00:0010-KStáhnout
2015-02-17 00:00:008-KStáhnout
2015-02-16 23:00:008-KStáhnout
2015-01-12 00:00:008-KStáhnout
2015-01-11 23:00:008-KStáhnout
2014-12-11 00:00:008-KStáhnout
2014-12-10 23:00:008-KStáhnout
2014-12-10 00:00:008-KStáhnout
2014-12-09 23:00:008-KStáhnout
2014-12-08 00:00:008-KStáhnout
2014-12-07 23:00:008-KStáhnout
2014-11-26 00:00:008-KStáhnout
2014-11-25 23:00:008-KStáhnout
2014-11-19 00:00:008-KStáhnout
2014-11-18 23:00:008-KStáhnout
2014-11-07 00:00:008-KStáhnout
2014-11-07 00:00:0010-QStáhnout
2014-11-06 23:00:008-KStáhnout
2014-11-06 23:00:0010-QStáhnout
2014-10-15 01:00:008-KStáhnout
2014-10-15 00:00:008-KStáhnout
2014-09-19 01:00:008-KStáhnout
2014-09-19 00:00:008-KStáhnout
2014-08-07 01:00:008-KStáhnout
2014-08-07 01:00:0010-QStáhnout
2014-08-07 00:00:008-KStáhnout
2014-08-07 00:00:0010-QStáhnout
2014-06-16 01:00:008-KStáhnout
2014-06-16 00:00:008-KStáhnout
2014-06-13 01:00:008-KStáhnout
2014-06-13 00:00:008-KStáhnout
2014-06-03 01:00:008-KStáhnout
2014-06-03 00:00:008-KStáhnout
2014-05-14 01:00:008-KStáhnout
2014-05-14 00:00:008-KStáhnout
2014-05-09 01:00:0010-QStáhnout
2014-05-09 00:00:0010-QStáhnout
2014-05-08 01:00:008-KStáhnout
2014-05-08 00:00:008-KStáhnout
2014-04-17 01:00:008-KStáhnout
2014-04-17 00:00:008-KStáhnout
2014-04-07 00:00:008-KStáhnout
2014-03-17 23:00:0010-KStáhnout
2014-03-05 23:00:008-KStáhnout
preloader